Pages that link to "Q24529156"
Jump to navigation
Jump to search
The following pages link to Human sodium channel myotonia: slowed channel inactivation due to substitutions for a glycine within the III-IV linker (Q24529156):
Displaying 50 items.
- potassium-aggravated myotonia (Q7234683) (← links)
- Practical aspects in the management of hypokalemic periodic paralysis (Q21245474) (← links)
- Functional consequences of a domain 1/S6 segment sodium channel mutation associated with painful congenital myotonia (Q22009453) (← links)
- Drug treatment for myotonia (Q24244905) (← links)
- Drug treatment for myotonia (Q24247351) (← links)
- SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome (Q24317024) (← links)
- Muscle channelopathies and critical points in functional and genetic studies (Q24532297) (← links)
- A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction (Q24626279) (← links)
- Characterization of a new sodium channel mutation at arginine 1448 associated with moderate Paramyotonia congenita in humans (Q24651364) (← links)
- Phenotypic variation of a Thr704Met mutation in skeletal sodium channel gene in a family with paralysis periodica paramyotonica (Q24672636) (← links)
- Myotonic disorders: A review article (Q26747746) (← links)
- Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison (Q26772794) (← links)
- Channelopathies of skeletal muscle excitability (Q28082428) (← links)
- Paramyotonia congenita: the R1448P Na+ channel mutation in adult human skeletal muscle (Q28277370) (← links)
- Nav 1.4 slow-inactivation: is it a player in the warm-up phenomenon of myotonic disorders? (Q28284919) (← links)
- Old gene duplication facilitates origin and diversification of an innovative communication system--twice (Q30497745) (← links)
- The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. (Q33570009) (← links)
- Clinical Diversity of SCN4A-Mutation-Associated Skeletal Muscle Sodium Channelopathy (Q33590751) (← links)
- Neurological channelopathies: diagnosis and therapy in the new millennium (Q33841654) (← links)
- Inherited disorders of voltage-gated sodium channels (Q33905815) (← links)
- Defective fast inactivation recovery and deactivation account for sodium channel myotonia in the I1160V mutant (Q33907568) (← links)
- Slow inactivation differs among mutant Na channels associated with myotonia and periodic paralysis (Q33915721) (← links)
- Are some idiopathic epilepsies disorders of ion channels?: A working hypothesis. (Q34016353) (← links)
- Physiologic basis of potentials recorded in electromyography (Q34071934) (← links)
- Clinical and genetic heterogeneity in myotonic dystrophies (Q34096504) (← links)
- Real-time imaging of electrical signals with an infrared FDA-approved dye. (Q34203755) (← links)
- EFNS Task Force on Molecular Diagnosis of Neurologic Disorders: guidelines for the molecular diagnosis of inherited neurologic diseases. Second of two parts. (Q34368117) (← links)
- Genetic disorders of neuromuscular ion channels (Q34811193) (← links)
- Phenotypic variation of Val1589Met mutation in a four-generation Chinese pedigree with mild paramyotonia congenitia: case report (Q35145290) (← links)
- Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. (Q35534007) (← links)
- Determining the Advantages, Costs, and Trade-Offs of a Novel Sodium Channel Mutation in the Copepod Acartia hudsonica to Paralytic Shellfish Toxins (PST). (Q35663867) (← links)
- Electrophysiology and molecular pharmacology of muscle channelopathies. (Q35843233) (← links)
- Pathophysiological role of omega pore current in channelopathies (Q36022793) (← links)
- Inactivation defects caused by myotonia-associated mutations in the sodium channel III-IV linker (Q36411785) (← links)
- Molecular analysis of potential hinge residues in the inactivation gate of brain type IIA Na+ channels (Q36411875) (← links)
- Mutation analysis in exons 22 and 24 of SCN4A gene in Iranian patients with non-dystrophic myotonia (Q36582941) (← links)
- A quantitative measure of handgrip myotonia in non-dystrophic myotonia (Q36587121) (← links)
- Voltage-gated sodium channels: action players with many faces (Q36652537) (← links)
- The dominant cold-sensitive Out-cold mutants of Drosophila melanogaster have novel missense mutations in the voltage-gated sodium channel gene paralytic (Q36936851) (← links)
- Neonatal hypotonia can be a sodium channelopathy: recognition of a new phenotype (Q37179038) (← links)
- Health status in non-dystrophic myotonias: close relation with pain and fatigue (Q37233918) (← links)
- Sodium channelopathies of skeletal muscle result from gain or loss of function (Q37711046) (← links)
- Hereditary Channelopathies in Neurology (Q37786254) (← links)
- Voltage-gated sodium channels: biophysics, pharmacology, and related channelopathies. (Q38026557) (← links)
- Diagnosis of skeletal muscle channelopathies (Q38143226) (← links)
- Mutational consequences of aberrant ion channels in neurological disorders (Q38239544) (← links)
- Skeletal muscle na channel disorders (Q38698910) (← links)
- Sequence CLCN1 and SCN4A in patients with Nondystrophic myotonias in Chinese populations: Genetic and pedigree analysis of 10 families and review of the literature (Q38896436) (← links)
- Mechanisms underlying a life-threatening skeletal muscle Na+ channel disorder (Q39552491) (← links)
- New mutation of the Na channel in the severe form of potassium-aggravated myotonia. (Q39863856) (← links)